APP and Alzheimer disease: The integration of biochemical and genetic evidence substantiates an intuitive molecular mechanism to AD, whereby the sequential proteolytic cleavage of APP by β-secretase (BACE1) and γ-secretase (containing PSEN1/PSEN2) produces amyloidogenic Aβ peptides [18–20].